JPH02131494A - Crystal or sodium l-ascorbate 2-phosphate and production thereof - Google Patents
Crystal or sodium l-ascorbate 2-phosphate and production thereofInfo
- Publication number
- JPH02131494A JPH02131494A JP21805289A JP21805289A JPH02131494A JP H02131494 A JPH02131494 A JP H02131494A JP 21805289 A JP21805289 A JP 21805289A JP 21805289 A JP21805289 A JP 21805289A JP H02131494 A JPH02131494 A JP H02131494A
- Authority
- JP
- Japan
- Prior art keywords
- salt
- solution
- ascorbic acid
- phosphate
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013078 crystal Substances 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 title abstract 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 35
- 238000010992 reflux Methods 0.000 claims abstract description 12
- -1 aliphatic alcohols Chemical class 0.000 claims abstract description 9
- 239000003960 organic solvent Substances 0.000 claims abstract description 9
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 150000002576 ketones Chemical class 0.000 claims abstract description 5
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 4
- 150000004292 cyclic ethers Chemical class 0.000 claims abstract description 4
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims description 32
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
- 159000000003 magnesium salts Chemical group 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 159000000007 calcium salts Chemical class 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical group [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 2
- HYHGLHONPBPZGJ-YCWPWOODSA-L disodium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] phosphate Chemical compound [Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP(O)([O-])=O)=C1[O-] HYHGLHONPBPZGJ-YCWPWOODSA-L 0.000 claims 7
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 33
- 238000000034 method Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000012264 purified product Substances 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000003957 anion exchange resin Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 150000003018 phosphorus compounds Chemical class 0.000 description 2
- 238000000634 powder X-ray diffraction Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000520323 Sphingomonas trueperi Species 0.000 description 1
- 241001061127 Thione Species 0.000 description 1
- POXJXWXPDYFTJM-ZAFYKAAXSA-N [(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-yl] dihydrogen phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1OP(O)(O)=O POXJXWXPDYFTJM-ZAFYKAAXSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- SFKTYEXKZXBQRQ-UHFFFAOYSA-J thorium(4+);tetrahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[Th+4] SFKTYEXKZXBQRQ-UHFFFAOYSA-J 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、し−アスコルビン酸−2−リン酸(以下、A
sA2Pと略記する。)のナトリウム塩(以下、Na塩
と略記する。)結晶およびその製法に関する。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to the use of thi-ascorbic acid-2-phosphate (hereinafter referred to as A
It is abbreviated as sA2P. ) crystals of sodium salt (hereinafter abbreviated as Na salt) and its production method.
AsA2PNa塩の結晶は、アスコルビン酸の安定化誘
導体として有用であり、医薬品、食品、化粧品その他各
種の工業分野に使用され得る。Crystals of AsA2PNa salt are useful as a stabilized derivative of ascorbic acid, and can be used in pharmaceuticals, foods, cosmetics, and various other industrial fields.
従来の技術 従来、AsA2Fに関する報告は数多く知られている。Conventional technology Conventionally, many reports regarding AsA2F have been known.
たとえば、ビタミン(Vitamins ; Japa
n)41巻(1970年)の387〜398ページには
アスコルビン酸リン酸エステルの化学と応用について書
かれており、とくに390ページにはアスコルビン酸−
3−リン酸エステルのマグネシウム塩、ナトリウム塩、
カルシウム塩の性質が書かれている。アスコルビン酸−
3へリン酸ナトリウム塩の性質については無色粉末で結
晶しがたいと記載されている。なお、この文献のアスコ
ルビン酸−3−リン酸は、ビタミン51巻(1985年
)の185ページでAsA2Pに訂正されている。For example, vitamins
n) Volume 41 (1970), pages 387 to 398, describe the chemistry and applications of ascorbic acid phosphate, and in particular, page 390 describes ascorbic acid phosphate.
Magnesium salt, sodium salt of 3-phosphate ester,
The properties of calcium salts are described. Ascorbic acid-
Regarding the properties of sodium 3-hephosphate, it is described that it is a colorless powder and does not easily crystallize. Note that ascorbic acid-3-phosphate in this document has been corrected to AsA2P on page 185 of Vitamin Vol. 51 (1985).
その他、AsA2Pの精製法として、活性炭を用いる方
法(特開昭59−5 1293、特開昭59−1064
94)、強酸性陽イオン交換樹脂を用いる方法、強塩基
性陰イオン交換樹脂を用いる方法(特公昭45−449
7>、弱塩基性または中塩基性陰イオン交換樹脂を用い
る方法(特開昭62−30791) 、弱酸型キレート
樹脂を用いる方法(特開昭62−103096)などの
方法が知られている。In addition, as a method for purifying AsA2P, there is a method using activated carbon (JP-A-59-5-1293, JP-A-59-1064).
94), method using strongly acidic cation exchange resin, method using strongly basic anion exchange resin (Japanese Patent Publication No. 45-449
7>, a method using a weakly basic or medium basic anion exchange resin (JP-A-62-30791), a method using a weak acid type chelate resin (JP-A-62-103096), and other methods are known.
特開昭59−51293号公報には、目的物である精製
後のAsA2Pを脱カチオン処理した後、塩の形にする
のが好ましいと書かれている。塩の形として、マグネシ
ウム塩、カルシウム塩、ナトリウム塩、カリウム塩など
が記されている。さらに、このようにして得られる目的
物を含有する液を通常おこなわれる濃縮工程、晶出工程
に付す、とも書かれているが、実施例はすべてマグネシ
ウム塩に関するものばかりで、ナ} IJウム塩の結晶
については書かれていない。また、本発明者はこの公報
記載の方法でナトリウム塩の結晶を得ようと試みたが、
結晶はできずアメ状のものができたにすぎなかった。JP-A-59-51293 states that it is preferable to decationize the purified AsA2P, which is the target product, and then convert it into a salt form. The salt forms listed include magnesium salt, calcium salt, sodium salt, and potassium salt. Furthermore, it is written that the solution containing the target product obtained in this way is subjected to the usual concentration step and crystallization step, but all the examples are related to magnesium salts, and the examples are all about magnesium salts. There is no mention of crystals. The inventor also attempted to obtain crystals of sodium salt by the method described in this publication, but
No crystals were formed, just a candy-like substance.
発明が解決しようとする課題
一般的にAsA2PはMg塩の形で実用化されているが
、その精製過程、製品の使用の際に以下に述べる点が問
題となっている。Problems to be Solved by the Invention Generally, AsA2P is put to practical use in the form of Mg salt, but the following problems arise in its purification process and in the use of the product.
■ AsA2PMg塩は、非品質であるため晶析によっ
て高純度のAsA2PMg塩を得るのは困難である。特
に、反応原料の未反応物及び副生物として生成するリン
化合物が不溶性のMg塩を形成して精製を困難にしてい
る。(2) As AsA2PMg salt is of poor quality, it is difficult to obtain high purity AsA2PMg salt by crystallization. In particular, unreacted materials from the reaction raw materials and phosphorus compounds produced as by-products form insoluble Mg salts, making purification difficult.
■ AsΔ2PMg塩は、非品質のため、含水率、溶媒
残留率が高く、また、乾燥による付着水分や溶媒の除去
も容易ではない。(2) Since AsΔ2PMg salt is of low quality, it has a high moisture content and solvent residual rate, and it is not easy to remove attached moisture and solvent by drying.
■ AsA2PMg塩は水に対して溶解速度が遅く、ア
メ状になりやすい。そのため工業的実用濃度に溶解する
には、溶解時の分散方法を工夫する必要がある。■ AsA2PMg salt has a slow dissolution rate in water and tends to become candy-like. Therefore, in order to dissolve it at an industrially practical concentration, it is necessary to devise a dispersion method during dissolution.
■ AsA2PMg塩を用いる場合、水が存在する系で
は経時的に徐々に着色してしまう。(2) When AsA2PMg salt is used, it gradually becomes colored over time in a system where water is present.
そこで安定で取り扱い易い形態の八sA2Pの開発が望
まれている。Therefore, it is desired to develop 8sA2P in a stable and easy-to-handle form.
課題を解決するための手段
本発明によれば、安定で取り扱い易く、高純度のAsA
2Pが、新規なAsA2PNa塩の結晶として提供され
る。Means for Solving the Problems According to the present invention, stable, easy-to-handle, and highly purified AsA
2P is provided as a novel AsA2PNa salt crystal.
本発明の71.sA2PNa塩の結晶は、AsΔ2Pを
含有する溶液を、水酸化ナ} IJウムでpH8〜10
に調整し、この溶液を40〜80℃の温度で加熱・還流
しながら、炭素数5以下の低級脂肪族アルコール、炭素
数5以下の脂肪族飽和ケトンおよび環状エーテルから選
ばれる有機溶媒を溶液中の濃度が30〜80%(v/v
)となるように4〜7時間かけて該溶液に徐々に添加し
た後、30℃以下の温度で放置することによって得られ
る。71 of the present invention. Crystals of sA2PNa salt can be obtained by adjusting a solution containing AsΔ2P to pH 8-10 with sodium hydroxide.
While heating and refluxing this solution at a temperature of 40 to 80°C, an organic solvent selected from lower aliphatic alcohols having 5 or less carbon atoms, aliphatic saturated ketones having 5 or less carbon atoms, and cyclic ethers is added to the solution. The concentration of 30-80% (v/v
) is gradually added to the solution over 4 to 7 hours, and then allowed to stand at a temperature of 30° C. or lower.
本発明のAsΔ2PNa塩の結晶の物性を以下に示す。The physical properties of the AsΔ2PNa salt crystal of the present invention are shown below.
(1)元素分析値
(2)分子量 ;331.0(元素分析からCsHsO
sPNa* j ′AH20と推定)(3》x線回折図
;Cu一K2線を用い粉末X線回折法で測定して得ら
れたX線回折図形を第1図に示す。なお、図中の数字は
第1表の番号に対応する。比較強度は、図中のピーク2
を100として表わしている。(1) Elemental analysis value (2) Molecular weight; 331.0 (from elemental analysis CsHsO
sPNa* j 'AH20) (3) X-ray diffraction pattern; Figure 1 shows the X-ray diffraction pattern obtained by measuring with the powder X-ray diffraction method using the Cu-K2 line. The numbers correspond to those in Table 1. The comparative intensities are peak 2 in the figure.
is expressed as 100.
第 1 表
(4)赤外線吸収スペクトル; KBr錠剤法で測定
した赤外線吸収スペクトルを第2図に示す。Table 1 (4) Infrared absorption spectrum; The infrared absorption spectrum measured by the KBr tablet method is shown in FIG.
(5)溶剤に対する溶解性; 水には溶け易いが、低級
アルコール類、ケトン類には溶けにくい。(5) Solubility in solvents: Easily soluble in water, but difficult to dissolve in lower alcohols and ketones.
エーテルにはほとんど溶けない。Almost insoluble in ether.
第3図にNa塩、Mg塩の比較溶解速度を示す。Figure 3 shows the comparative dissolution rates of Na salt and Mg salt.
(6)塩基性、酸性、中性の区別; 弱塩基性(7)物
質の色 ; 無色透明
(8)結晶の形 ; 通常は柱状晶になる。(6) Distinction between basic, acidic, and neutral; Weakly basic (7) Color of substance; Colorless and transparent (8) Crystal shape; Usually columnar crystals.
本発明で用いる出発溶液はAsA2Pを含有する液であ
ればAsA2P溶液、AsA2Pの金属塩溶液もしくは
アルカリ土類金属塩一容液などいずれも対象とすること
ができる。例えば、アスコルビン酸とリン酸供与体とか
ら酵素あるいは微生物の作用によって生成したAsA2
P含有液は好適に利用できる。金属塩としてはカリウム
塩、アルカリ土類金属塩としてはマグネシウム塩、カル
シウム塩があげられる。The starting solution used in the present invention may be any liquid containing AsA2P, such as an AsA2P solution, a metal salt solution of AsA2P, or a one-volume solution of an alkaline earth metal salt. For example, AsA2 is produced from ascorbic acid and a phosphate donor by the action of enzymes or microorganisms.
A P-containing liquid can be suitably used. Examples of metal salts include potassium salts, and examples of alkaline earth metal salts include magnesium salts and calcium salts.
AsA2Fが塩の形である場合、あるいはAs八2P含
有液がアルカリ金属、アルカリ土類金属等の金属イオン
を含有する場合はその水溶液を適当なイオン交換樹脂で
処理して脱力チオンすることが望ましい。AsA2Pを
イオン交換樹脂に吸着させ、0. 1〜2Nの希塩酸で
溶出した後、水酸化“子トリウムでpH1!!整が行わ
れる。When AsA2F is in the form of a salt, or when the As82P-containing solution contains metal ions such as alkali metals and alkaline earth metals, it is desirable to treat the aqueous solution with a suitable ion exchange resin to remove thione. . AsA2P is adsorbed onto an ion exchange resin, and 0. After elution with 1-2N diluted hydrochloric acid, the pH is adjusted to 1!! with thorium hydroxide.
水酸化ナ}IJウムによるpH調整は、通常5〜15N
の水酸化ナ}IJウム水溶液で行われる。pH adjustment with sodium hydroxide is usually 5 to 15N.
It is carried out in an aqueous solution of sodium hydroxide.
pHAl1整後の溶液中のAsA2P濃度は30〜10
0g/1、好ましくは50〜80g/βであり、必要に
応じて水で希釈し、あるいは減圧濃縮等によって濃縮さ
れる。The AsA2P concentration in the solution after adjusting pHAl1 is 30-10
The amount is 0 g/1, preferably 50 to 80 g/β, and if necessary, it is diluted with water or concentrated by vacuum concentration or the like.
次いで該溶液を40〜80t好ましくは50〜70℃の
温度で加熱還流しながら有機溶媒をその濃度が30〜8
0%(v/v)になるように4〜7時間かけてゆっくり
添加して結晶を晶出させる。必要に応じてさらに加熱還
流を2〜10時間継続する。Next, the solution is heated under reflux for 40 to 80 tons, preferably at a temperature of 50 to 70°C, and the organic solvent is reduced to a concentration of 30 to 8.
The mixture is slowly added over 4 to 7 hours so that the concentration becomes 0% (v/v), and crystals are crystallized. Heating and refluxing is further continued for 2 to 10 hours as necessary.
用いられる有機溶媒としてはメタノール、エタノール等
の炭素数5以下の低級脂肪族アルコール、アセトンなど
の炭素数5以下の脂肪族飽和ケトン類、テトテヒド口フ
ラン等の環状エーテルが例示される。これらの有機溶媒
は、単独でも混合しても用いられる。Examples of the organic solvents used include lower aliphatic alcohols having 5 or less carbon atoms such as methanol and ethanol, aliphatic saturated ketones having 5 or less carbon atoms such as acetone, and cyclic ethers such as tetotehydefuran. These organic solvents may be used alone or in combination.
加熱、還流後30℃以下の温度に放置すると晶出した結
晶が生長、熟成する。結晶はp過によって単離し、前記
有機溶媒で洗浄した後、真空乾燥等の処理によって高純
度の白色結晶状AsA2PNa塩が得られる。After heating and refluxing, if the mixture is left at a temperature of 30° C. or lower, the crystals will grow and ripen. The crystals are isolated by p-filtration, washed with the above-mentioned organic solvent, and then subjected to treatments such as vacuum drying to obtain a highly pure white crystalline AsA2PNa salt.
本発明方法によればASA2P生成反応の反応液中の未
反応リン化合物はナトリウムと溶解度の高い塩を形成す
るので製品への混入量が少なく、結晶の晶出母液からの
分離性が良く、再結晶操作の回数が少なくてすむ。According to the method of the present invention, unreacted phosphorus compounds in the reaction solution of the ASA2P production reaction form highly soluble salts with sodium, so the amount of contamination in the product is small, crystals can be easily separated from the crystallization mother liquor, and they can be recycled. Fewer crystal operations are required.
又得られた結晶は含水率が少なく、付着水分、溶媒の除
去が容易で、溶解速度が速い。Furthermore, the obtained crystals have a low water content, allowing easy removal of attached water and solvent, and a fast dissolution rate.
本発明の態様を実施例によって説明する。Aspects of the present invention will be illustrated by examples.
実施例l.
シュードモナス・アゾトコリガンス^TCC 1241
7をポリペプトン10g/R、肉エキス7 g/12,
酵母エキス5 g / lおよびNaCJ! 3g/
1を含むp H 7. 2に調整した培地(以下、KM
l02培地と略す。)30mlに植菌し、30℃で20
時間培養した。ついでKM I O 2培地300ml
に上記で得られた種培養液12mlを植菌し、30℃で
、20時間培養した。得られた培養液を10, OOO
X gにて10分間遠心分離し、湿菌体1 1. 8
gを得て、20℃にて凍結保存した。凍結保存菌体50
mg/ml(湿菌体重量)を含むアスコルビン酸2 0
0 m!J,ビロリン酸カリウム200mM,酢酸ナ
トリウム緩衝液(p}I 4. 0> 1 0 0 m
M,ナイミーンS−215(日本油脂社製)4g/j!
、キシレンloml/j!の組成の反応液50mlを、
マグネチック・スター?ーにて1 0 O rpmで攪
拌しつつ、水酸化ナトリウムでpl{を4.0付近に、
温度を40℃に保っ■て36時間反応させた。得られた
反応液(A s A2F30g/1含む。)II!を徐
閉p過し、p液をプロライトA’10O(中塩基性陰イ
オン交換樹脂、プロライト・インターナショナル社製)
1lを充填した塔に通液した。吸着したA s A2P
をIN希塩酸で溶離した。Example l. Pseudomonas azotocolligans ^TCC 1241
7, polypeptone 10g/R, meat extract 7g/12,
Yeast extract 5 g/l and NaCJ! 3g/
pH 7. Medium adjusted to 2 (hereinafter referred to as KM
It is abbreviated as 102 medium. ) Inoculate 30ml and incubate at 30℃ for 20
Cultured for hours. Next, 300 ml of KM I O 2 medium
12 ml of the seed culture solution obtained above was inoculated and cultured at 30° C. for 20 hours. The obtained culture solution was diluted with 10,000
Centrifuge at Xg for 10 minutes to remove wet bacterial cells 1. 8
g was obtained and stored frozen at 20°C. Cryopreserved bacterial cells 50
Ascorbic acid containing mg/ml (wet bacterial weight) 20
0 m! J, potassium birophosphate 200mM, sodium acetate buffer (p}I 4.0>100m
M, Naimeen S-215 (manufactured by NOF Corporation) 4g/j!
, xylene loml/j! 50 ml of the reaction solution with the composition of
Magnetic star? While stirring at 10 O rpm, adjust the PL to around 4.0 with sodium hydroxide.
The temperature was maintained at 40°C and the reaction was carried out for 36 hours. Obtained reaction solution (contains 30 g/1 of A s A2F) II! The p solution was passed through a slow closed p filter, and the p solution was passed through Prolyte A'10O (medium basic anion exchange resin, manufactured by Prolyte International).
The solution was passed through a column filled with 1 liter. Adsorbed A s A2P
was eluted with IN dilute hydrochloric acid.
溶離により得られた溶液をION水酸化ナ} IJウム
水溶液でpH 9. 5に調整した。The solution obtained by elution was adjusted to pH 9.0 with an aqueous solution of ION sodium hydroxide. Adjusted to 5.
この液のAsA2Fの濃度を80g/1に減圧濃縮後0
.45ミクロンのミリポアフィルターを用いて戸過した
。p液を60℃に加熱還流、攪拌しながら、メタノール
900mlを約6時間かけてゆっくり加え、その後3時
間加熱還流を継続した。The AsA2F concentration of this solution was concentrated under reduced pressure to 80 g/1.
.. Passed through a 45 micron Millipore filter. The p solution was heated to 60° C. under reflux, and while stirring, 900 ml of methanol was slowly added over about 6 hours, and then heated under reflux for 3 hours.
30℃以下で一晩放置した。生じた結晶を戸過し、メタ
ノールで洗浄した。次いで40℃で一夜真空乾燥して目
的とするAsA2PNa塩の結晶の精製品 21.4g
(収$71%)を得た。得られた精製品の製品分析値を
第1表に示す。It was left at 30°C or lower overnight. The resulting crystals were filtered and washed with methanol. Next, vacuum drying at 40°C overnight yields 21.4 g of purified AsA2PNa salt crystals.
(Yield: $71%). Product analysis values of the obtained purified product are shown in Table 1.
実施例2.
実施例1と同様な方法によって得られたΔsA2P20
.Og/Ilを含有する反応液をIN水酸化ナトリウム
水溶液でp H 4. 0に調整し、粉末活性炭4gを
添加し、50℃で30分間放置して脱色後戸過しだ。p
液を再度IN水酸化ナ} IJウム水溶液でp H 9
. 5に調整し、AsA2P 80g/lになるよう
減圧濃縮した。濃縮液300mlを60℃に加熱還流攪
拌しなからアセトン600mlを6時間かけてゆっくり
加え、さらに3時間還流した後5℃で3時間放置した。Example 2. ΔsA2P20 obtained by a method similar to Example 1
.. The reaction solution containing Og/Il was adjusted to pH 4.0 with an IN aqueous sodium hydroxide solution. 0, 4 g of powdered activated carbon was added, and the mixture was left to stand at 50°C for 30 minutes to decolorize it, and then filtered. p
The solution was again adjusted to pH 9 with an aqueous solution of sodium hydroxide and sodium hydroxide.
.. 5 and concentrated under reduced pressure to AsA2P 80 g/l. 300 ml of the concentrated solution was heated to 60° C. under reflux and stirred, then 600 ml of acetone was slowly added over 6 hours, refluxed for an additional 3 hours, and then left at 5° C. for 3 hours.
生じた結晶を戸過し、アセトンで洗浄した。次いで40
℃で一夜真空乾煙し、目的とするA SA 2 P N
aの結晶の精製品16.5g(収率80%》を得た。The resulting crystals were filtered and washed with acetone. then 40
Vacuum dry at ℃ overnight to obtain the desired A SA 2 P N
16.5 g (yield: 80%) of purified crystals of a were obtained.
実施例3.
AsΔ2PMg塩(未精製品)50.0gをI+W f
i水llに溶解した。この溶液をダイヤイオンSK−I
B (強酸性陽イオン交換樹脂,三菱化成社製)500
mlを充填した塔に通液し、脱力チオンした。Example 3. I + W f of 50.0 g of AsΔ2PMg salt (unrefined product)
Dissolved in 1 liter of water. Add this solution to Diaion SK-I
B (strongly acidic cation exchange resin, manufactured by Mitsubishi Chemical Corporation) 500
The solution was passed through a column filled with 1.0 ml of the solution to remove thion.
流出液をIN水酸化ナ} IJウム水溶液でp H 9
. 5に調整し、粉末活性炭5gで脱色後戸過した。p
液を実施例1と同様に晶析、乾燥し目的とするAsA2
PNa塩の結晶の精製品4 2. 5 g (収率85
%)を得た。得られた精製品の製品分析値をyg2表に
示す。The effluent was adjusted to pH 9 with an aqueous solution of IN sodium hydroxide.
.. After decolorizing with 5 g of powdered activated carbon, the mixture was filtered. p
The liquid was crystallized and dried in the same manner as in Example 1 to obtain the desired AsA2.
Purified PNa salt crystal product 4 2. 5 g (yield 85
%) was obtained. The product analysis values of the obtained purified product are shown in Table yg2.
比較例
実施例lと同様な方法によ1て得られたAsA2P
20.Og/Jを含有するIN希塩酸溶液をIN水酸化
マグネシウム溶液でpH8に調整した。粉末活性炭で脱
色戸過し、p液のA s A2Pの濃度を50g/1に
なる迄減圧濃縮し、濃縮液を60℃に加熱攪拌しながら
これにメタノール900mlを6時間かけてゆっくり添
加した。さらに3時間還流後冷却し一夜30℃以下で放
置し生じた沈殿物を戸過し、乾燥してAsA2PMg塩
の精製品22.5g(収率75%)を得た。得られた精
製品の製品分析値を第2表に示す。Comparative Example AsA2P obtained by the same method as Example 1
20. The IN dilute hydrochloric acid solution containing Og/J was adjusted to pH 8 with IN magnesium hydroxide solution. The mixture was decolorized using powdered activated carbon and concentrated under reduced pressure until the concentration of A s A2P in the p solution became 50 g/1. The concentrated solution was heated to 60° C. and 900 ml of methanol was slowly added thereto over 6 hours while stirring. After further refluxing for 3 hours, the mixture was cooled and left at 30° C. or below overnight, and the resulting precipitate was filtered out and dried to obtain 22.5 g (yield: 75%) of a purified product of AsA2PMg salt. Product analysis values of the obtained purified product are shown in Table 2.
第 2 表(Na塩と1塩の製品分析》本発明によりA
sA2PNa塩の結晶が、高純度、高収率で提供される
。Table 2 (Product analysis of Na salt and 1 salt) According to the present invention, A
Crystals of sA2PNa salt are provided with high purity and high yield.
第1図は、本発明のAsA2PNa塩結晶の粉末X線回
折図形である。
第2図は、AsA2PNa塩結晶の赤外線吸収スペクト
ルであり、第3図は、ΔS A2P N a塩結晶、A
sA2PMg塩の溶解速度を比較したものである。図中
、1はA s A2P N a塩結晶、2はAsA2P
Mg塩を示す。
なお、第1図の縦軸は回折強度、横軸は回折角度を示し
、第2図の縦軸は透過率、横軸は波数を示す。第3図の
縦軸は、上澄中のAsA2P濃度、横軸は攪拌溶解時間
を示す。
第4図はAsA2PNa塩結晶の写真(200倍)であ
る。FIG. 1 is a powder X-ray diffraction pattern of AsA2PNa salt crystals of the present invention. Figure 2 is an infrared absorption spectrum of AsA2PNa salt crystal, and Figure 3 is an infrared absorption spectrum of AsA2PNa salt crystal, A
A comparison of the dissolution rates of sA2PMg salts. In the figure, 1 is AsA2P Na salt crystal, 2 is AsA2P
Indicates Mg salt. In addition, the vertical axis of FIG. 1 shows the diffraction intensity and the horizontal axis shows the diffraction angle, and the vertical axis of FIG. 2 shows the transmittance and the horizontal axis shows the wave number. In FIG. 3, the vertical axis shows the AsA2P concentration in the supernatant, and the horizontal axis shows the stirring dissolution time. FIG. 4 is a photograph (200x magnification) of AsA2PNa salt crystals.
Claims (8)
結晶。(1) Crystals of L-ascorbic acid-2-phosphate sodium salt.
の分子式で示されるL−アスコルビン酸−2−リン酸ナ
トリウム塩の結晶。(2) C_6H_6O_9PNa_3・1/2H_2O
A crystal of L-ascorbic acid-2-phosphate sodium salt shown by the molecular formula.
を、水酸化ナトリウムでpH8〜10に調整し、この溶
液を40〜80℃の温度で加熱・還流しながら、炭素数
5以下の低級脂肪族アルコール、炭素数5以下の脂肪族
飽和ケトンおよび環状エーテルから選ばれる有機溶媒を
溶液中の濃度が30〜80%(v/v)となるように4
〜7時間かけて該溶液に徐々に添加した後、30℃以下
の温度で放置することによりL−アスコルビン酸−2−
リン酸ナトリウム塩を晶出させることを特徴とする結晶
状L−アスコルビン酸−2−リン酸ナトリウム塩の製造
法。(3) A solution containing L-ascorbic acid-2-phosphoric acid is adjusted to pH 8 to 10 with sodium hydroxide, and while heating and refluxing this solution at a temperature of 40 to 80°C, An organic solvent selected from lower aliphatic alcohols, aliphatic saturated ketones having 5 or less carbon atoms, and cyclic ethers is added so that the concentration in the solution is 30 to 80% (v/v).
L-ascorbic acid-2-
A method for producing crystalline L-ascorbic acid-2-phosphate sodium salt, which comprises crystallizing the sodium phosphate salt.
はアルカリ土類金属塩を含有する溶液を脱カチオン処理
した後、水酸化ナトリウムでpH8〜10に調整し、こ
の溶液を40〜80℃の温度で加熱・還流しながら炭素
数5以下の低級脂肪族アルコール、炭素数5以下の脂肪
族飽和ケトンおよび環状エーテルから選ばれる有機溶媒
を溶液中の濃度が30〜80%(v/v)となるように
4〜7時間かけて該溶液に徐々に添加した後、30℃以
下の温度で放置することによりL−アスコルビン酸−2
−リン酸ナトリウム塩を晶出させることを特徴とする結
晶状L−アスコルビン酸−2−リン酸ナトリウム塩の製
造法。(4) After decationizing the solution containing the metal salt or alkaline earth metal salt of L-ascorbic acid-2-phosphoric acid, the pH was adjusted to 8 to 10 with sodium hydroxide, and the solution was heated at 40 to 80°C. While heating and refluxing at a temperature of After gradually adding it to the solution over 4 to 7 hours so that
- A method for producing crystalline L-ascorbic acid-2-phosphate sodium salt, which comprises crystallizing the sodium phosphate salt.
晶状L−アスコルビン酸−2−リン酸ナトリウム塩の製
造法。(5) The method for producing crystalline L-ascorbic acid-2-phosphate sodium salt according to claim (4), wherein the metal salt is a potassium salt.
ルシウム塩である請求項(4)記載の結晶状L−アスコ
ルビン酸−2−リン酸ナトリウム塩の製造法。(6) The method for producing crystalline L-ascorbic acid-2-phosphate sodium salt according to claim (4), wherein the alkaline earth metal salt is a magnesium salt or a calcium salt.
還流を継続することを特徴とする請求項(3)、(4)
の結晶状L−アスコルビン酸−2−リン酸ナトリウム塩
の製造法。(7) Claims (3) and (4) characterized in that after adding the organic solvent, heating and refluxing is continued for an additional 2 to 10 hours.
A method for producing crystalline L-ascorbic acid-2-phosphate sodium salt.
またはテトラヒドロフランの少なくとも一種である請求
項(3)、(4)の結晶状L−アスコルビン酸−2−リ
ン酸の製造法。(8) The method for producing crystalline L-ascorbic acid-2-phosphoric acid according to claims (3) and (4), wherein the organic solvent is at least one of methanol, ethanol, acetone, or tetrahydrofuran.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1218052A JP2877366B2 (en) | 1988-08-25 | 1989-08-24 | Method for producing crystalline L-ascorbic acid-2-phosphate sodium salt |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21110088 | 1988-08-25 | ||
JP63-211100 | 1988-08-25 | ||
JP1218052A JP2877366B2 (en) | 1988-08-25 | 1989-08-24 | Method for producing crystalline L-ascorbic acid-2-phosphate sodium salt |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13153698A Division JP3117949B2 (en) | 1989-08-24 | 1998-05-14 | Crystals of L-ascorbic acid-2-phosphate sodium salt |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02131494A true JPH02131494A (en) | 1990-05-21 |
JP2877366B2 JP2877366B2 (en) | 1999-03-31 |
Family
ID=26518437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1218052A Expired - Lifetime JP2877366B2 (en) | 1988-08-25 | 1989-08-24 | Method for producing crystalline L-ascorbic acid-2-phosphate sodium salt |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2877366B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6121464A (en) * | 1998-07-13 | 2000-09-19 | Basf Ag | Preparation of salts of ascorbyl 2-phosphoric esters |
WO2002070531A1 (en) * | 2001-03-02 | 2002-09-12 | Showa Denko K.K. | Ascorbic acid 2-phosphate metal salt with low calcium content |
JP2007516952A (en) | 2003-12-26 | 2007-06-28 | 日産化学工業株式会社 | Crystalline form of quinoline compound and process for producing the same |
-
1989
- 1989-08-24 JP JP1218052A patent/JP2877366B2/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6121464A (en) * | 1998-07-13 | 2000-09-19 | Basf Ag | Preparation of salts of ascorbyl 2-phosphoric esters |
EP0972777A3 (en) * | 1998-07-13 | 2000-12-27 | Basf Aktiengesellschaft | Process for the preparation of salts of ascorbyl-2-phosphoric acid esters |
WO2002070531A1 (en) * | 2001-03-02 | 2002-09-12 | Showa Denko K.K. | Ascorbic acid 2-phosphate metal salt with low calcium content |
JP2007516952A (en) | 2003-12-26 | 2007-06-28 | 日産化学工業株式会社 | Crystalline form of quinoline compound and process for producing the same |
JP2014205719A (en) * | 2003-12-26 | 2014-10-30 | 日産化学工業株式会社 | Crystal form of quinoline compound and method for producing the same |
Also Published As
Publication number | Publication date |
---|---|
JP2877366B2 (en) | 1999-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108779186A (en) | A kind of improved method for preparing the more glucose that relaxes | |
JPH02167286A (en) | Salt of clavulanic acid, and production and use | |
CZ54495A3 (en) | Process for preparing and/or purification of clavulanic acid | |
US20180305388A1 (en) | Crystal of 6'-sialyllactose sodium salt, and process for producing same | |
US6121464A (en) | Preparation of salts of ascorbyl 2-phosphoric esters | |
HU212578B (en) | Process for producing high purity potassium salt of clavulanic acid with purification of unrefined clavulanic acid using n,n'-substituted ethylendiammonium-diclavulanate and process for producing ethylen diammonium-diclavulanats | |
US4456753A (en) | Process for the manufacture of highly crystalline sodium cefoperazone | |
US4515943A (en) | Crystal of beta-nicotinamide-adenine-dinucleotide and process for preparing the same | |
JPH02131494A (en) | Crystal or sodium l-ascorbate 2-phosphate and production thereof | |
JP4130177B2 (en) | Method for producing high purity riboflavin-5'-phosphate sodium salt | |
EP1474375A1 (en) | Process for the isolation of polyhydroxy cyclic carboxylic acids | |
CN105481895A (en) | Highly pure Vc-2-sodium monophosphate preparation method and highly pure Vc-2-sodium monophosphate prepared through method | |
JPH02174789A (en) | Preparation of riboflavin-4', 5'-cyclophosphoric ester chloride and riboflavin-5'-phosphate(5'-fmn) or sodium salt thereof | |
CN112010805B (en) | Refining method of fasudil hydrochloride | |
JP3117949B2 (en) | Crystals of L-ascorbic acid-2-phosphate sodium salt | |
JP3378847B2 (en) | Crystals of L-ascorbic acid-2-phosphate sodium salt | |
JP2022550078A (en) | Method for producing disodium 5'-guanylate heptahydrate crystals | |
JP4200593B2 (en) | Crystalline L-ascorbic acid-2-phosphate sodium salt and process for producing the same | |
JP3750160B2 (en) | Amorphous L-ascorbic acid-2-phosphate ester sodium salt and method for producing the same | |
US3784562A (en) | Methyl acetoacetic ester enamine of d-2-(1,4-cyclohexadien-1-yl)glycine, sodium salt-dimethylformamide adduct | |
EP0962461B1 (en) | Crystalline potassium salt of L-ascorbic acid-2-phosphoric acid and method for producting the same | |
US2891051A (en) | Adducts of salts of novobiocin | |
EP1072605B1 (en) | Process for producing ascorbic acid-2-phosphoric ester salts | |
KR100532573B1 (en) | Process for preparation of Magnesium L-ascorbyl-2-phosphate | |
US6271397B1 (en) | L-ascorbic acid-2-phosphoric acid potassium crystal and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080122 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090122 Year of fee payment: 10 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090122 Year of fee payment: 10 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090122 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100122 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100122 Year of fee payment: 11 |